Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes
Combination therapy for type 2 diabetes using agents with complementary mechanisms of action may improve glycemic control to a greater extent than monotherapy and allow the use of lower doses of antihyperglycemic medications. Dipeptidyl peptidase-4 inhibitors, including saxagliptin, are recommended...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
American Diabetes Association
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220591/ |